Rudolf
0 Reviews
Senior M&A Director & Global Head | Master PE Cases, Commercial DD & Senior Hire Interviews
M&A & Commercial Due Diligence,
Private Equity (PE) & Value Creation
Market Entry & Growth Strategy
English, German
Germany (UTC +1)
USD 149 / h
Senior M&A Director & Global Head | Master PE Cases, Commercial DD & Senior Hire Interviews
M&A & Commercial Due Diligence,
Private Equity (PE) & Value Creation
Market Entry & Growth Strategy
USD 149 / h
Statistics
Finance
0 Coachings
0 Q&A Upvotes
0 Awards
About Rudolf
Coaching Approach
Work Experience

I am not a junior consultant teaching you theory. I am a Global Head & Board Member at a Private Equity-backed MedTech leader, and I spent 7 years driving M&A and Corporate Strategy at a DAX-listed healthcare giant (Fresenius).

I hire people. I lead Commercial Due Diligences. I decide which companies we buy.

Why work with me?

Most candidates fail because they "solve the math" but miss the commercial reality. I will train you to bridge that gap.

For Experienced Hires: I help you translate your industry experience into "Consulting Speak" to pass the Partner Interview.

For High Potentials: We won't just do market sizing. We will simulate Real-Life PE & M&A Cases (Carve-outs, Synergy targets, Buy-and-Build) that I actually executed.

My Background:

Current: Global Head of Business Development & Board Member (Schwind eye-tech-solutions, PE-backed).  

Previous: Senior Director Strategy & M&A (Fresenius Medical Care).  

Expertise: Commercial Due Diligence, Value Creation, Post-Merger Integration.  

The Offer:

I offer a highly realistic, pressure-tested interview simulation. I will challenge your logic, your structure, and your presence—just like a Partner would.

If you want to move from "memorizing frameworks" to demonstrating executive presence, let’s talk.

As a Global Head in a PE-backed company and former M&A Director, I specialize in preparing candidates for high-stakes interviews in Private Equity, Corporate M&A, and Strategy Consulting.

Show more
Work Experience
Senior Director/ Head of Strategy, M&A & Portfolio
Fresenius Medical Care
2023 - 2023

▪ Portfolio Optimization (ROCE): Analyzed the global asset portfolio to identify non-core assets. Initiated potential divestitures and carve-outs to streamline operations and significantly improve Return on Capital Employed (ROCE) ▪ Inorganic Growth Strategy: Defined the long-term M&A strategy for the Critical Care division, aligning investment priorities with global market trends and clinical gaps

Global Head of Business Development
Schwind eye-tech-solutions
2023 - now

▪ Commercial Strategy & Route-to-Market Transformation:

• Direct Sales Expansion: Executed a strategic shift from indirect distributor models to Direct Sales organizations in key growth markets (India, UK, LATAM). Successfully captured full value chain margin and secured direct customer access

• Market Entry & Governance: Established the Legal Entity in India and appointed to the Board of Directors to oversee regional governance, compliance, and scaling operations

• China Growth Strategy: Defined and executed the dedicated Go-To-Market Strategy for China, including the successful market launch of the Femto Laser portfolio, navigating complex regulatory and competitive landscapes

• Commercial Excellence: Designed and executed a global "Value-Based Pricing" strategy, successfully defending premium margins against commoditization pressures. Implemented advanced Sales & AR (Augmented Reality) Tools to modernize the customer acquisition journey

▪ Product Management & Organizational Build-up:

• Department Structure: Built the Global Product Management function from scratch, replacing fragmented responsibilities with a centralized, accountable unit

• Process Excellence: Implemented a rigorous E2E Product Lifecycle Management process, including standardized requirements engineering and interface definitions (R&D/Sales), significantly reducing time-to-market

• Portfolio Execution: Orchestrated the global launch of high-impact capital equipment (ATOS, SmartSight NOVA, CenTrax, ForeSight) and the high-margin service product TheraCare, diversifying the revenue mix

▪ Digital Strategy & Value Creation:

• Business Model Pivot: Architected the company's transition towards data-driven revenue models. Developed the "Schwind Connectivity & Application Platform" (Launch 2026) to enable SaaS/AI-based monetization, deepen the "Digital Moat" around the installed base

Director Strategy, Business Development and M&A
Fresenius Medical Care AG
2022 - 2023

▪ Buy-and-Build Execution: Led end-to-end M&A processes from target sourcing to deal execution. Successfully managed cross-functional deal teams through valuation, negotiation, and closing ▪ Commercial Due Diligence: Focused on rigorous commercial assessment of targets, analyzing pricing power, reimbursement status (Market Access), and competitive positioning rather than just financial history ▪ Strategic Partnerships: Negotiated and structured cross-border joint ventures and technology licensing agreements to close portfolio gaps rapidly without heavy internal R&D spend

Chief of Staff/ Executive Project Manager CEO GRD
Fresenius Medical Care AG
2021 - 2022

▪ Performance Improvement (FME25): Co-led a global restructuring workstream focusing on G&A efficiency and operating model redesign. Identified and realized significant cost-saving potentials to boost group-wide EBITDA ▪ Venture Capital & Spin-Offs: Managed Series A/B fundraising and spin-off activities for biotech assets (e.g., Unicyte AG), demonstrating deep understanding of capital markets and valuation

Education
Master student
University of Applied Sciences Amberg-Weiden
2015 - 2016
Biomedical Engineering